| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.09 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |